Ruihong Wang

Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials

D. Schrump, R. Fietkau, Jian-Guo Zhou, 2021, Frontiers in Immunology.

Universal Markers for hiPSCs Residue Detection.

Yuchun Gu, Hui Shi, Lida Wu, 2022, Frontiers in bioscience.

Editorial: Uncovering Drug Resistance During Cancer Therapy

A. Wong, Haitao Wang, Weilong Hou, 2022, Frontiers in genetics.